{"date":"2026-03-31","count":59,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6841-2026-03-31-2339-1v64wrq","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"23:39:33","subject":"本公司董事會決議通過現金增資子公司長聯科技股份有限公司","clause":"第20款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-31 23:39，「本公司董事會決議通過現金增資子公司長聯科技股份有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-31-2326-4g83i0","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"23:26:26","subject":"公告本公司董事會決議召開115年股東常會相關事宜(增列召集事由)","clause":"第32款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-31 23:26，「公告本公司董事會決議召開115年股東常會相關事宜(增列召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-31-2325-180gpkr","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"23:25:34","subject":"公告本公司董事會決議召開115年第一次股東臨時會相關事宜(增列召集事由)","clause":"第32款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-31 23:25，「公告本公司董事會決議召開115年第一次股東臨時會相關事宜(增列召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-03-31-2300-dk594a","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"23:00:43","subject":"公告本公司接獲合作夥伴Boryung Biopharma Co. Ltd.通知已向韓國食品藥物安全部(MFDS)遞交抗流感病毒新藥Pixavirmarboxil(TG-1000)膠囊三期臨床試驗許可之申請(IND)","clause":"第10款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-03-31 23:00，「公告本公司接獲合作夥伴Boryung Biopharma Co. Ltd.通知已向韓國食品藥物安全部(MFDS)遞交抗流」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-03-31-2148-1l694ux","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"21:48:28","subject":"代重要子公司Belite Bio, Inc公告LBS-008針對斯特格病變青少年病患之全球第三期臨床試驗取得最終臨床試驗報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-03-31 21:48，「代重要子公司Belite Bio, Inc公告LBS-008針對斯特格病變青少年病患之全球第三期臨床試驗取得最終臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-03-31-2119-v3nfvy","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"21:19:54","subject":"獨立董事對董事會議案表示反對意見","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-03-31 21:19，「獨立董事對董事會議案表示反對意見」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-03-31-2118-11qiaz3","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"21:18:24","subject":"本公司董事會決議召開115年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-03-31 21:18，「本公司董事會決議召開115年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-03-31-2117-mkv97r","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"21:17:15","subject":"公告本公司董事會決議召開115年股東常會日期暨相關事宜(增加議案)","clause":"第32款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-03-31 21:17，「公告本公司董事會決議召開115年股東常會日期暨相關事宜(增加議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-03-31-2115-10fn4ra","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"21:15:51","subject":"公告本公司董事會重大決議事項","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-03-31 21:15，「公告本公司董事會重大決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-03-31-2113-1v08jg1","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"21:13:50","subject":"公告本公司董事會決議辦理私募發行普通股","clause":"第9款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-03-31 21:13，「公告本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-31-2045-1pzjlpi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"20:45:08","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-31 20:45，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-31-2039-1wpp3mb","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"20:39:34","subject":"公告本公司董事會決議擬辦理私募普通股案","clause":"第9款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-31 20:39，「公告本公司董事會決議擬辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-31-2038-cwxd6c","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"20:38:17","subject":"公告本公司董事會決議通過發行115年度第一次員工認股權憑證","clause":"第9款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-31 20:38，「公告本公司董事會決議通過發行115年度第一次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-31-2037-3sk96k","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"20:37:46","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"第9款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-31 20:37，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-03-31-2037-1phcwdn","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"20:37:15","subject":"公告本公司董事會決議不繼續辦理民國114年第一次股東臨時會通過之私募普通股或私募國內可轉換公司債案","clause":"第14款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-03-31 20:37，「公告本公司董事會決議不繼續辦理民國114年第一次股東臨時會通過之私募普通股或私募國內可轉換公司債案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-03-31-1902-1jv93md","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"19:02:48","subject":"公告本公司115年2月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-03-31 19:02，「公告本公司115年2月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1816-j7etzg","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"18:16:55","subject":"代子公司明睿(股)公司公告董事會通過減資彌補虧損案","clause":"第9款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 18:16，「代子公司明睿(股)公司公告董事會通過減資彌補虧損案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1816-1bm2ov4","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"18:16:44","subject":"公告本公司董事會決議通過初次上市(櫃)，擬以現金增資發行新股辦理公開承銷，原股東全數放棄現金增資優先認股之權利案。","clause":"第9款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 18:16，「公告本公司董事會決議通過初次上市(櫃)，擬以現金增資發行新股辦理公開承銷，原股東全數放棄現金增資優先認股之權利案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1816-1n8cuzx","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"18:16:32","subject":"公告本公司董事會決議通過申請股票上市(櫃)案。","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 18:16，「公告本公司董事會決議通過申請股票上市(櫃)案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1816-1wt2l8m","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"18:16:17","subject":"公告本公司董事會決議通過114年度合併財務報表","clause":"第43款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 18:16，「公告本公司董事會決議通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1815-2dvlbn","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"18:15:40","subject":"公告本公司董事會決議通過114年度員工及董事酬勞分派情形案。","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 18:15，「公告本公司董事會決議通過114年度員工及董事酬勞分派情形案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-03-31-1758-b3xgxd","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:58:53","subject":"公告本公司114年現金增資案股款未於繳款期間內收足","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-03-31 17:58，「公告本公司114年現金增資案股款未於繳款期間內收足」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-31-1756-1yxrkav","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"17:56:22","subject":"代孫公司得益生物科技(股)公司公告向關係人取得使用權資產","clause":"第20款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-31 17:56，「代孫公司得益生物科技(股)公司公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-03-31-1755-skuqs8","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"17:55:51","subject":"代子公司豐華生物科技(股)公司公告向關係人處分使用權資產(轉租部分廠房)","clause":"第20款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-03-31 17:55，「代子公司豐華生物科技(股)公司公告向關係人處分使用權資產(轉租部分廠房)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1742-1pghq2o","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:42:02","subject":"公告本公司董事會決議通過114年度現金股利暨資本公積發放現金案","clause":"第31款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 17:42，「公告本公司董事會決議通過114年度現金股利暨資本公積發放現金案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-03-31-1726-fqsc9p","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:26:25","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-03-31 17:26，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-31-1718-v5n95d","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"17:18:25","subject":"公告本公司115年2月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-31 17:18，「公告本公司115年2月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-03-31-1715-1rz18e4","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:15:27","subject":"本公司研發主管職務異動案","clause":"第11款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-03-31 17:15，「本公司研發主管職務異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-03-31-1714-ueirm1","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:14:57","subject":"公告本公司董事會決議114年下半年度股利分派","clause":"第31款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-03-31 17:14，「公告本公司董事會決議114年下半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-03-31-1714-3141u0","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:14:41","subject":"公告本公司董事會決議114年度員工酬勞及董事酬勞分派案","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-03-31 17:14，「公告本公司董事會決議114年度員工酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-03-31-1714-11b1948","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:14:17","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-03-31 17:14，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-03-31-1713-1b89la1","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"17:13:53","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-03-31 17:13，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-31-1702-17lnd4r","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"17:02:24","subject":"公告本公司董事會決議更換會計師事務所及簽證會計師","clause":"第7款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-31 17:02，「公告本公司董事會決議更換會計師事務所及簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-31-1654-hk2f6k","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"16:54:32","subject":"公告本公司買回庫藏股執行完畢","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-31 16:54，「公告本公司買回庫藏股執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-03-31-1634-1prr7k6","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:34:58","subject":"公告本公司第三次庫藏股買回期間屆滿執行情形","clause":"第35款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-03-31 16:34，「公告本公司第三次庫藏股買回期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-31-1634-f7ebbw","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:34:42","subject":"更正本公司114年度合併財報之IXBRL申報資訊","clause":"第51款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-31 16:34，「更正本公司114年度合併財報之IXBRL申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-31-1626-1fweyex","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:26:24","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-31 16:26，「代重要子公司Alvogen Korea Holdings Ltd.公告董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-31-1625-udss0n","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:25:18","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告2026年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-31 16:25，「代重要子公司Alvogen Korea Holdings Ltd.公告2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-31-1624-dpqybr","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:24:41","subject":"代重要子公司Alvogen Korea Co., Ltd.公告監察人當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-31 16:24，「代重要子公司Alvogen Korea Co., Ltd.公告監察人當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-31-1623-1n5osjp","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:23:34","subject":"代重要子公司Alvogen Korea Co., Ltd.公告董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-31 16:23，「代重要子公司Alvogen Korea Co., Ltd.公告董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-31-1622-15wciib","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:22:34","subject":"代重要子公司Alvogen Korea Co., Ltd.公告2026年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-31 16:22，「代重要子公司Alvogen Korea Co., Ltd.公告2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-03-31-1620-sd5vu0","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"16:20:53","subject":"瑞士商赫爾辛保健公司主張本公司嘔克朗產品侵害其專利權請求損害賠償之訴訟判決","clause":"第2款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-03-31 16:20，「瑞士商赫爾辛保健公司主張本公司嘔克朗產品侵害其專利權請求損害賠償之訴訟判決」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-31-1611-1mvy42n","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"16:11:32","subject":"公告本公司董事會決議股利分派情形","clause":"第31款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-31 16:11，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-31-1608-1a3rlp8","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"16:08:25","subject":"召開115年度股東常會","clause":"第32款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-31 16:08，「召開115年度股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-31-1606-13snlot","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"16:06:16","subject":"公告本公司114年底累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-31 16:06，「公告本公司114年底累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-31-1605-5j9yh6","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"16:05:27","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-31 16:05，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-03-31-1601-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"16:01:33","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-03-31 16:01，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-31-1546-1hutdoa","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"15:46:10","subject":"公告本公司產品開發暨行銷長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-31 15:46，「公告本公司產品開發暨行銷長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-31-1540-1ph5301","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"15:40:52","subject":"公告本公司發言人及會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-31 15:40，「公告本公司發言人及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-31-1539-15w1hx6","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"15:39:46","subject":"公告本公司董事會決議召開115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-31 15:39，「公告本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-03-31-1528-1h3ceio","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"15:28:47","subject":"公告本公司董事會決議買回庫藏股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-03-31 15:28，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-31-1517-j03sr5","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"15:17:49","subject":"公告本公司115年02月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第44款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-31 15:17，「公告本公司115年02月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-03-31-1515-13m2zxy","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"15:15:19","subject":"公告本公司發言人、財務主管暨會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-03-31 15:15，「公告本公司發言人、財務主管暨會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-03-31-1502-13rpxz5","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"15:02:14","subject":"公告本公司訂定除息基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-03-31 15:02，「公告本公司訂定除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-03-31-1349-ak3jmg","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"13:49:30","subject":"公告本公司研發中新藥 SR-T100 注射劑（治療癌症惡性腹水）已取得財團法人醫藥品查驗中心(CDE)諮詢回覆，將正式向TFDA申請第一期人體臨床試驗","clause":"第53款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-03-31 13:49，「公告本公司研發中新藥 SR-T100 注射劑（治療癌症惡性腹水）已取得財團法人醫藥品查驗中心(CDE)諮詢回覆，將正式向」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-03-31-1337-1bkm0mx","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-03-31","time":"13:37:00","subject":"公告本公司代理發言人異動","clause":"第8款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-03-31 13:37，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-03-31-1333-1bkm0mx","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-03-31","time":"13:33:32","subject":"公告本公司代理發言人異動","clause":"第11款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-03-31 13:33，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-03-31-1322-k905ao","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"13:22:00","subject":"公告更補正本公司114年度合併財報、114年度個體財報部分內容誤植","clause":"第53款","fact_date":"2026-03-31","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-03-31 13:22，「公告更補正本公司114年度合併財報、114年度個體財報部分內容誤植」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-03-31-1118-dw621t","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-31","time":"11:18:57","subject":"合富-KY董事會決議召開115年股東常會公告（新增召集事由）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-03-31 11:18，「合富-KY董事會決議召開115年股東常會公告（新增召集事由）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}